How much funding has Numan raised?

Numan has raised $53.2M in total funding, most recently a Series B round.

Who are Numan's investors?

Numan's investors include Novator, Kreos Capital, White Star Capital, VNV Global, Anthemis Exponential Ventures, Colle Capital Partners.

Where is Numan headquartered?

Numan is headquartered in London, United Kingdom.

Numan

Your healthcare co-pilot

London, United Kingdom · Founded 2018 · $53.2M raised

Healthcare

Headquarters: London
Employees: 201–500
Founded: 2018
Business Model: B2C

Website: numan.com
Total Funding: $53.2M
Last Round: $40.0M Series BSep 2021
Rounds: 3

About

Founded in 2018 and headquartered in London, UK, Numan (a trading name of Vir Health Limited) is a digital healthcare company on a mission to make people healthier through convenient, personalised care. Originally a men's health platform, Numan has expanded to treat common health conditions including weight loss, erectile dysfunction, hair loss, and general diagnostics, offering both prescription medication and evidence-based wellness plans. The company operates a CQC-regulated, GPhC-licensed pharmacy and employs clinicians, pharmacists, and healthcare professionals alongside its technology team. Numan combines clinical expertise with a digital-first approach, providing access to its services via web and mobile app. The company has grown its revenue approximately 7x in three years and employs close to 500 staff, with 35% having a medical background. Numan is registered in England and Wales (company number 11449267) and is positioned as a leading UK digital health provider expanding from prescriptions into preventative health.

Summary

Numan is a Healthcare company based in London, United Kingdom, founded in 2018. It has raised $53.2M in total across 3 rounds, most recently a $40.0M Series B round in Sep 2021. Investors include Novator, Kreos Capital and White Star Capital.